Owner Merck & Co., Inc.

Inventors Nargund, Ravi P.; Palucki, Brenda L.

Agent Spruson & Ferguson

Pub. Number AU-B-2001249281

PCT Pub. Number WO01/70337

Priority 60191669 23.03.00 US

Filing date 20 March 2001

Wipo publication date 3 October 2001

Acceptance publication date 27 January 2005

A61P 015/00 Drugs for genital or sexual disorders

C07D 417/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 413/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 401/00 Heterocyclic compounds containing two or more hetero rings

C07D 223/14 Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/50 - Pyridazines

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/54 - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61K 031/535 - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61P 015/10 Drugs for genital or sexual disorders